Core Points - The stock of Huaren Health experienced a decline of 2.04% on November 20, with a trading volume of 188 million yuan [1] - The company reported a financing buy-in amount of 17.215 million yuan and a financing repayment of 27.0689 million yuan on the same day, resulting in a net financing outflow of 9.8538 million yuan [1] - As of November 20, the total financing and securities lending balance for Huaren Health was 161 million yuan, with the financing balance accounting for 7.48% of the circulating market value, indicating a high level compared to the past year [1] Financing and Securities Lending - On November 20, Huaren Health had a financing buy-in of 17.215 million yuan, with a current financing balance of 161 million yuan, which is above the 90th percentile of the past year [1] - The securities lending data showed no shares were repaid or sold on November 20, with a total securities lending balance of 0, indicating a low level compared to the past year [1] Company Overview - Huaren Health, established on June 29, 2001, is located at 123 A1 Building, Hebei Road, Hefei City, Anhui Province, and was listed on March 1, 2023 [1] - The company's main business involves pharmaceutical agency, retail, and terminal procurement, with the revenue composition being 97.60% from traditional Chinese and Western medicine and 2.40% from other sources [1] Financial Performance - For the period from January to September 2025, Huaren Health achieved an operating income of 3.892 billion yuan, representing a year-on-year growth of 19.06% [2] - The net profit attributable to the parent company for the same period was 157 million yuan, reflecting a year-on-year increase of 45.21% [2] Shareholder Information - As of September 30, 2025, the number of shareholders for Huaren Health was 20,100, a decrease of 22.86% from the previous period [2] - The average number of circulating shares per shareholder increased by 29.64% to 7,422 shares [2] - The total cash dividends distributed by Huaren Health since its A-share listing amounted to 80.020 million yuan [3] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited held 2.3203 million shares, an increase of 1.3357 million shares compared to the previous period [3]
华人健康11月20日获融资买入1721.50万元，融资余额1.61亿元